Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1Breast Cancer Metastatic 1

Interventions

Fulvestrant 5dalpiciclib 3Letrozole 3ribociclib 2palbociclib 2fluzoparib 2exemestane 2apatinib 2Anastrozole 2trastuzumab deruxtecan 1sacituzumab govitecan 1pyrotinib 1pegfilgrastim 1patritumab deruxtecan 1olaparib 1irinotecan sucrosofate 1abemaciclib 1Zoledronic Acid 1Rogaratinib 1Patient Reported Outcome Measures 1Paclitaxel 1Neoadjuvant Therapy 1Liposomes 1Irinotecan 1Ga(III)-DOTATOC 1Everolimus 1Cell Separation 1Capecitabine 1Bevacizumab 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Cancer Metastatic × Cell Separation × Clear all
NCT04047459 2019-08-06

Investigation of Cancer Cell Extravasation Through mRNA Analysis of Organ-specific Endothelial Cells and Microfluidics

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Completed
31 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡